Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-10-24
2009-10-27
Ouspenski, Ilia (Department: 1644)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S455000, C435S325000
Reexamination Certificate
active
07608425
ABSTRACT:
Disclosed are compositions and methods for increasing the longevity of a cell culture and permitting the increased production of proteins, preferably recombinant proteins, such as antibodies, peptides, enzymes, growth factors, interleukins, interferons, hormones, and vaccines. Cells transfected with an apoptosis-inhibiting gene or vector, such as a triple mutant Bcl-2 gene, can survive longer in culture, resulting in extension of the state and yield of protein biosynthesis. Such transfected cells exhibit maximal cell densities that equal or exceed the maximal density achieved by the parent cell lines. Transfected cells can also be pre-adapted for growth in serum-free medium, greatly decreasing the time required to obtain protein production in serum-free medium. In certain methods, the pre-adapted cells can be used for protein production following transfection under serum-free conditions. In preferred embodiments, the cells of use are SpESF or SpESF-X cells.
REFERENCES:
patent: 6586206 (2003-07-01), Dixit et al.
patent: 6635448 (2003-10-01), Bucciarelli et al.
patent: 6964199 (2005-11-01), Lee et al.
patent: 7531327 (2009-05-01), Goldenberg et al.
patent: 2003/0064510 (2003-04-01), Reff et al.
patent: 2003/0069201 (2003-04-01), Reed
patent: 2003/0219871 (2003-11-01), Enenkel et al.
patent: 2007/0015250 (2007-01-01), Goldenberg et al.
patent: 2007/0092947 (2007-04-01), Goldenberg et al.
patent: 02/16590 (2002-02-01), None
patent: 02/40665 (2002-05-01), None
patent: 03/040374 (2003-05-01), None
patent: 03/083093 (2003-10-01), None
patent: 2007/015848 (2007-02-01), None
Arden et al. “Cell engineering blocks stress and improves biotherapeutic production”, Bioprocessing Journal, 3:23-28 (2004).
Brenner et al. “Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation”, Oncogene 17:199-205, 1998.
Chang et al. “Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases”, Proc Natl Acad Sci USA 97, 4291-6, 2000.
Deng et al. “Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions”, PNAS (101) 153-158, 2004.
Deng et al. “Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS” Blood, vol. 102, No. 9, pp. 3179-3185, 2003.
Finzer et al. “The role of human papillomavirus oncoproteins E6 and E7 in apoptosis”, Cancer Lett 188, 15-24, 2002.
Geisse et al. “Eukaryotic Expression Systems: A Comparison” Protein Expression and Purification 8:271-282 (1996).
Ghezzi and Brines “Erythropoietin as an antiapoptotic, tissue-protective cytokine”, Cell Death and Differentiation 11 (suppl. 1), s37-s44, Jul. 2004.
Gillies et al. “High-level expression of chimeric antibodies using adapted cDNA variable region cassettes”, J. Immunol. Methods 125:191 (1989).
Goldstein and Singal “Senescence of Cultured Human Fibroblasts: Mitotic Versus Metabolic Time”, Exp Cell Res 88, 359-64, 1974.
Javelaud et al. “Induction of p21Waf1/Cip1 by TNFa requires NF-kB activity and antagonizes apoptosis in Ewing tumor cells”, Oncogene 19, 61-8, 2000.
Lee et al. “Human papilloma virus type 16 E7 genes protect astrocytes against apoptotic and necrotic death induced by hydrogen peroxide”, Yonsei Med J 42, 471-9, 2001.
Lee et al. “Development of Apoptosis-Resistant Dihydrofolate Reductase-Deficient Chinese Hamster Ovary Cell Line”, Biotechnology & Bioengineering 82:872-76, 2003.
Lotem et al. “Regulation by bcl-2, c-myc, and p53 of Susceptibility to Induction of Apoptosis by Heat Shock and Cancer Chemotherapy Compounds in Differentiation-competent and -defective Myeloid Leukemic Cells”, Cell Growth & Differentiation, 4:41-47, 1993.
Schwartz et al. “In vitro Meylopoiesis Stimulated by Rapid Medium Exchange and Supplementation with Hematopoietic Growth Factors”, Blood 78(12):3155-61, 1991 (Abstract only).
Suzuki et al. “Establishing Apoptosis Resistant Cell Lines for Improving Protein Productivity of Cell Culture” Cytotechnology 23:55-59, 1997.
Romanos et al. “Production of a phosphorylated GST:HPV-6 E7 fusion protein using a yeast expression vector and glutathione S-transferase fusions”, Gene, vol. 152, No. 1, pp. 137-138, 1995.
Tey et al. “Influence of Bcl-2 on cell death during cultivation of a Chinese Hamster Ovary cell line expressing a chimeric antibody”, Biotechnol. Bioeng. 68: 31-43, 2000.
Vaux et al. “BcI-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells”, Nature 335, 440-2, 1988.
Yang et al. “Inhibitors Directed towards Caspase-1 and -3 Are Less Effective than Pan Caspase Inhibition in Preventing Renal Proximal Tubular Cell Apoptosis”, Nephron Experimental Nephrology 2004;96:e39-e51.
Chang Chien-Hsing
Goldenberg David M.
Nordstrom Diane
Rossi Edward A.
Immunomedics Inc.
Nakashima Richard A.
Ouspenski Ilia
LandOfFree
Methods for protein expression in mammalian cells in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for protein expression in mammalian cells in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for protein expression in mammalian cells in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4139569